Die Nutzung von Geninformationen für eine personalisierte Pharmakotherapie: Stand, Zukunftspotenziale und wirtschaftliche Implikationen
作者： Stefan Sohn , Philipp Dornstauder , Oliver Schöffski
DOI: 10.1007/BF03320769
关键词:
摘要: Objective In pharmacotherapy „personalised medicine“ based on genetic information has developed in recent years. To assess its implications a review was conducted current status, prospective potential and impact health expenditures.
springer.com
sci-hub.se 参考文章(45)
Mara G. Aspinall, Richard G. Hamermesh, Realizing the Promise of Personalized Medicine Harvard Business Review. ,vol. 85, pp. 108- 117 ,(2007)
I. Roots, G. Laschinski, F. Arjomand-Nahad, J. Kirchheiner, D. Schwarz, J. Brockmöller, I. Cascorbi, T. Gerloff, Genotype and Phenotype Relationship in Drug Metabolism Ernst Schering Research Foundation Workshop. pp. 81- 100 ,(2007) , 10.1007/978-3-540-49529-1_6
C. Hengstenberg, G. Riegger, G. Schmitz, M. Fischer, A. Baessler, Paradigmenwechsel im Gesundheitswesen - Paradigmenwandel in der Medizin. Prospektion, Prävention und Personalisierung Deutsche Medizinische Wochenschrift. ,vol. 131, pp. 278- 281 ,(2006)
J. Kirchheiner, A. Seeringer, CYP2D6-, CYP2C9- und CYP2C19-basierte Arzneimitteldosisanpassungen Der Internist. ,vol. 49, pp. 877- 883 ,(2008) , 10.1007/S00108-008-2125-9
C.E. Reeder, W. Michael Dickson, Economic Implications of Pharmacogenomics Pharmacogenomics. pp. 227- 250 ,(2003) , 10.1002/047142613X.CH12
Penelope K. Manasco, Teresa E. Arledge, Drug Development Strategies Pharmacogenomics. pp. 83- 97 ,(2003) , 10.1002/047142613X.CH5
Francis S. Collins, Mark A. Rothstein, Pharmacogenomics : social, ethical, and clinical dimensions Wiley-Liss. ,(2003)
Gilbert S. Omenn, Arno G. Motulsky, Integration of Pharmacogenomics into Medical Practice Pharmacogenomics. pp. 135- 161 ,(2003) , 10.1002/047142613X.CH8
Madlaina Costa-Scharplatz, Antoinette D.I. van Asselt, Lucas M. Bachmann, Alfons G.H. Kessels, Johan L. Severens, Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor. Pharmacogenetics and Genomics. ,vol. 17, pp. 359- 368 ,(2007) , 10.1097/01.FPC.0000236336.34175.E8
Jason Lazarou, Bruce H. Pomeranz, Paul N. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies JAMA. ,vol. 279, pp. 1200- 1205 ,(1998) , 10.1001/JAMA.279.15.1200